Authors' Reply: A Crystal-Independent Role for Uric Acid in AKI Associated with Tumor Lysis Syndrome
- PMID: 36719149
- PMCID: PMC10101627
- DOI: 10.1681/ASN.2022101097
Authors' Reply: A Crystal-Independent Role for Uric Acid in AKI Associated with Tumor Lysis Syndrome
Conflict of interest statement
L. Zafrani reports Research Funding: Jazz Pharmaceuticals. The remaining author has nothing to disclose.
Comment on
-
Tumor Lysis Syndrome and AKI: Beyond Crystal Mechanisms.J Am Soc Nephrol. 2022 Jun;33(6):1154-1171. doi: 10.1681/ASN.2021070997. Epub 2022 May 6. J Am Soc Nephrol. 2022. PMID: 35523579 Free PMC article.
-
A Crystal-Independent Role for Uric Acid in AKI Associated with Tumor Lysis Syndrome.J Am Soc Nephrol. 2023 Jan 1;34(1):175. doi: 10.1681/ASN.0000000000000018. J Am Soc Nephrol. 2023. PMID: 36719148 Free PMC article. No abstract available.
References
-
- Ejaz AA, Mohandas R, Beaver TM, Johnson RJ. A crystal-independent role for uric acid in AKI associated with tumor lysis syndrome. J Am Soc Nephrol. 2023;34(1):175. doi:10.1681/ASN.2022080948 - DOI - PMC - PubMed
-
- Cortes J Moore JO Maziarz RT, et al. . Control of plasma uric acid in adults at risk for tumor lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone—results of a multicenter phase III study. J Clin Oncol. 2010;28(27):4207-4213. doi:10.1200/jco.2009.26.8896 - DOI - PMC - PubMed
-
- Darmon M Vincent F Camous L, et al. . Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique. Br J Haematol. 2013;162(4):489-497. doi:10.1111/bjh.12415 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
